James Kihara, Principal Accounting Officer at ACADIA PHARMACEUTICALS INC (ACAD), sold 1,025 shares at $27.05 ($28K) on 2022-04-08, disclosed to the SEC on 2022-04-11.
Open-market sale of $28k ACAD by Principal Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ACAD | SELL | 2026-05-05 | $29K | — | Filing → |
| ACAD | SELL | 2026-04-07 | $23K | — | Filing → |
| ACAD | SELL | 2026-03-26 | $42K | — | Filing → |